Global Forum on Nicotine (GFN) 2016 Jun 16, 2016 20160616 Jun 18, 2016 Warsaw Marriott Hotel, 79, Aleje Jerozolimskie 65, Warsaw 00-697, Poland This is a multi-stakeholder event that last year included participants from 44 countries. Participants comprised of policy analysts, regulators and standards experts, academics and researchers, parliamentarians, public health professionals, consumer advocates, and makers and distributors of alternative nicotine products – all with an interest in nicotine and its uses. This year the agenda for the conference will be crafted to address 3 key issues: Evidence, Accountability and Transparency. The programme will follow the pattern set by previous events. There will be a mixture of plenary, parallel, workshop and satellite sessions, an exhibition of scientific posters, as well as plenty of opportunities to network informally, including during the pre-conference social event.   FOLLOW ALL DETAILS ON TWITTER  #GFN16 /content/dam/pmiscience/default-fallback-thumbnails/conference/pmi-science-inside-laboratory-fallback.png

      Global Forum on Nicotine (GFN) 2016

      Date
      Jun 16, 2016 - Jun 18, 2016
      Location
      Warsaw Marriott Hotel, 79, Aleje Jerozolimskie 65, Warsaw 00-697, Poland
      This is a multi-stakeholder event that last year included participants from 44 countries. Participants comprised of policy analysts, regulators and standards experts, academics and researchers, parliamentarians, public health professionals, consumer advocates, and makers and distributors of alternative nicotine products – all with an interest in nicotine and its uses. This year the agenda for the conference will be crafted to address 3 key issues: Evidence, Accountability and Transparency. The programme will follow the pattern set by previous events. There will be a mixture of plenary, parallel, workshop and satellite sessions, an exhibition of scientific posters, as well as plenty of opportunities to network informally, including during the pre-conference social event.   FOLLOW ALL DETAILS ON TWITTER  #GFN16

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.

      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.